Price
$29.89
1M+6.3%1Y-
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Not rated
P/E (TTM)-
Market Cap$1.86B
1Y Return-
5Y Return-
Business segments
Q2 2026 · $29.4MThe company’s own SEC segment disclosure.
- Consumables$15.5M53%
- Instruments$7.8M26%
- Service$6.2M21%
Alamar Biosciences, Inc. (ALMR) reported revenue of $29M in Q2 2026 (quarter ended Jun 30, 2026), up 125% from the same quarter a year earlier. That came with a gross margin of 60% and net loss of $13M. Its largest product in Q2 2026 was Consumables at $15M, 53% of the disclosed total, well ahead of Instruments at 26%.
Raw charts
7 series · TTMAs reported to the SEC, without any scoring.
Medical Devices
The closest names by size in the same industry